Kezar Life Sciences, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KZR research report →
About the company
Kezar Life Sciences, Inc. is a United States-based clinical-stage biopharmaceutical company focused on identifying and advancing novel small molecule therapies. Its mission is to address significant unmet medical needs in both immune-mediated diseases and various forms of cancer.
- CEO
- Christopher J. Kirk
- IPO
- 2018
- Employees
- 55
- HQ
- South San Francisco, CA, US
Price Chart
- Market Cap
- $53.86M
- P/E
- -1.18
- P/S
- 0.00
- P/B
- 0.82
- EV/EBITDA
- 0.35
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -58.35%
- ROIC
- -63.08%
- Revenue
- $0 · 0.00%
- Net Income
- $-56,033,000 · 33.08%
- EPS
- $-7.66 · -566.09%
- Op Income
- $-52,270,000
- FCF YoY
- 30.25%
- 52W High
- $7.55
- 52W Low
- $3.53
- 50D MA
- $7.13
- 200D MA
- $5.81
- Beta
- 0.41
- Avg Volume
- 87.92K
Get TickerSpark's AI analysis on KZR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 11, 26 | Wallace Courtney | sell | 3,500 |
| May 11, 26 | Wallace Courtney | sell | 5,000 |
| May 11, 26 | Wallace Courtney | sell | 5,000 |
| May 11, 26 | Wallace Courtney | sell | 2,600 |
| May 11, 26 | Schiller Mark C. | other | 2,739 |
| May 11, 26 | Schiller Mark C. | sell | 25,000 |
| May 11, 26 | Schiller Mark C. | sell | 24,500 |
| May 11, 26 | Schiller Mark C. | sell | 12,000 |
| May 11, 26 | Schiller Mark C. | sell | 16,499 |
| May 11, 26 | Klearman Micki | sell | 3,500 |
Our KZR coverage
Recent articles, reports, and earnings notes.
No research on KZR yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate KZR report →Similar companies
Peers in the same neighborhood.